Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue

Detalhes bibliográficos
Autor(a) principal: Silva Filho,Edson
Data de Publicação: 2021
Outros Autores: Moura,Stephanney, Santos,Amilton da Cruz, Brasileiro-Santos,Maria do Socorro, Albuquerque,Jéssica Andrade de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100026
Resumo: SUMMARY The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcranial Direct Current Stimulation (tDCS) is a non-pharmacological tool that could be associated with pharmacological treatments to improve the central nervous system function and decrease the exacerbation of the immune system response. tDCS targeting pain and fatigue-related areas could provide an increase in neuroplasticity and enhancements in physical functions. Moreover, it can be used in infirmaries and clinical centers to treat COVID-19 patients.
id AMB-1_5045c095c6a6e6db5463f075a6ce8d73
oai_identifier_str oai:scielo:S0104-42302021000100026
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigueCoronavirus infectionsBetacoronavirusTranscranial direct current stimulationSUMMARY The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcranial Direct Current Stimulation (tDCS) is a non-pharmacological tool that could be associated with pharmacological treatments to improve the central nervous system function and decrease the exacerbation of the immune system response. tDCS targeting pain and fatigue-related areas could provide an increase in neuroplasticity and enhancements in physical functions. Moreover, it can be used in infirmaries and clinical centers to treat COVID-19 patients.Associação Médica Brasileira2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100026Revista da Associação Médica Brasileira v.67 n.1 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.67.01.20200671info:eu-repo/semantics/openAccessSilva Filho,EdsonMoura,StephanneySantos,Amilton da CruzBrasileiro-Santos,Maria do SocorroAlbuquerque,Jéssica Andrade deeng2021-06-16T00:00:00Zoai:scielo:S0104-42302021000100026Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-06-16T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
title Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
spellingShingle Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
Silva Filho,Edson
Coronavirus infections
Betacoronavirus
Transcranial direct current stimulation
title_short Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
title_full Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
title_fullStr Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
title_full_unstemmed Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
title_sort Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
author Silva Filho,Edson
author_facet Silva Filho,Edson
Moura,Stephanney
Santos,Amilton da Cruz
Brasileiro-Santos,Maria do Socorro
Albuquerque,Jéssica Andrade de
author_role author
author2 Moura,Stephanney
Santos,Amilton da Cruz
Brasileiro-Santos,Maria do Socorro
Albuquerque,Jéssica Andrade de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Silva Filho,Edson
Moura,Stephanney
Santos,Amilton da Cruz
Brasileiro-Santos,Maria do Socorro
Albuquerque,Jéssica Andrade de
dc.subject.por.fl_str_mv Coronavirus infections
Betacoronavirus
Transcranial direct current stimulation
topic Coronavirus infections
Betacoronavirus
Transcranial direct current stimulation
description SUMMARY The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcranial Direct Current Stimulation (tDCS) is a non-pharmacological tool that could be associated with pharmacological treatments to improve the central nervous system function and decrease the exacerbation of the immune system response. tDCS targeting pain and fatigue-related areas could provide an increase in neuroplasticity and enhancements in physical functions. Moreover, it can be used in infirmaries and clinical centers to treat COVID-19 patients.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100026
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000100026
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.67.01.20200671
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.67 n.1 2021
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212835677700096

Registros relacionados